Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: This is a spontaneous report from a contactable consumer, received via the regulatory authority (report number: GB-MHRA-WEBCOVID-202106050734458730-MCVI; safety report unique identifier: GB-MHRA-ADR 25425076). A patient, of unspecified age and gender, received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, administered in arm, on Jun 4, 2021, single dose, for COVID-19 immunisation. The patient medical history was not reported. Patient has not had symptoms associated with COVID-19. Patient was not enrolled in a clinical trial. The patient''s concomitant medications were not reported. The patient experienced pain and shoulder pain on Jun 4, 2021. Additional information: injection was given too high on the arm, which has resulted in severe shoulder joint pain. Unable to lift arm above head. Mobility severely limited since Jun 4, 2021. Pain relief did not help. The patient underwent lab tests, which included COVID-19 virus test: No - Negative COVID-19 test on an unknown date. Outcome of the events: not recovered. The regulatory authority assessed the events as medically significant. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166